Get the Stockscreener App
38.97
3.45%
1.30
After Hours:
38.70
-0.27
-0.69%
Gsk Plc Adr stock is traded at $38.97, with a volume of 7.85M.
It is up +3.45% in the last 24 hours and up +1.01% over the past month.
In the pharmaceutical industry, GSK ranks as one of the largest firms by total sales. The company wields its might across several therapeutic classes, including respiratory, antiviral, and vaccines, and has been growing its presence in oncology and immunology, as well. GSK uses joint ventures to gain additional scale in certain markets like HIV.
See More
Previous Close:
$37.67
Open:
$38.32
24h Volume:
7.85M
Relative Volume:
1.47
Market Cap:
$79.56B
Revenue:
$40.23B
Net Income/Loss:
$3.98B
P/E Ratio:
20.21
EPS:
1.9285
Net Cash Flow:
$4.94B
1W Performance:
+2.47%
1M Performance:
+1.01%
6M Performance:
+10.21%
1Y Performance:
-2.01%
1-Day Range:
$38.26
$39.16
1-Week Range:
$37.10
$39.16
52-Week Range:
$31.71
$44.67
Gsk Plc Adr Stock (GSK) Company Profile
Name
Gsk Plc Adr
Sector
Industry
Phone
-
Address
-
Compare GSK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
GSK
Gsk Plc Adr
|
38.97 | 76.02B | 40.23B | 3.98B | 4.94B | 1.9285 |
|
LLY
Lilly Eli Co
|
760.08 | 684.93B | 49.00B | 11.11B | -1.27B | 12.29 |
|
JNJ
Johnson Johnson
|
167.26 | 404.87B | 90.63B | 22.66B | 16.40B | 9.35 |
|
ABBV
Abbvie Inc
|
189.31 | 337.77B | 57.37B | 4.20B | 15.39B | 2.35 |
|
NVS
Novartis Ag Adr
|
116.63 | 226.92B | 55.19B | 13.65B | 16.81B | 6.86 |
|
MRK
Merck Co Inc
|
81.75 | 207.49B | 63.62B | 16.41B | 17.04B | 6.49 |
Gsk Plc Adr Stock (GSK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-03-25 | Downgrade | Berenberg | Buy → Hold |
| Apr-15-25 | Initiated | Exane BNP Paribas | Neutral |
| Feb-12-25 | Initiated | Morgan Stanley | Equal-Weight |
| Nov-15-24 | Downgrade | Deutsche Bank | Buy → Hold |
| Nov-12-24 | Downgrade | Jefferies | Buy → Hold |
| Oct-31-24 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-08-24 | Downgrade | UBS | Buy → Neutral |
| May-30-24 | Initiated | Goldman | Neutral |
| Mar-04-24 | Upgrade | Guggenheim | Neutral → Buy |
| Feb-13-24 | Upgrade | Citigroup | Neutral → Buy |
| Jan-23-24 | Initiated | Morgan Stanley | Equal-Weight |
| Jan-16-24 | Resumed | UBS | Buy |
| Jan-03-24 | Upgrade | Jefferies | Hold → Buy |
| Jul-14-23 | Initiated | HSBC Securities | Reduce |
| Mar-17-23 | Upgrade | Deutsche Bank | Hold → Buy |
| Feb-27-23 | Resumed | Goldman | Buy |
| Jan-03-23 | Downgrade | JP Morgan | Neutral → Underweight |
| Dec-05-22 | Downgrade | BofA Securities | Neutral → Underperform |
| Nov-11-22 | Downgrade | UBS | Neutral → Sell |
| Sep-15-22 | Upgrade | Credit Suisse | Underperform → Neutral |
| Sep-08-22 | Downgrade | Jefferies | Buy → Hold |
| Aug-05-22 | Resumed | Morgan Stanley | Equal-Weight |
| Jul-21-22 | Resumed | Citigroup | Neutral |
| Feb-11-22 | Downgrade | DZ Bank | Buy → Hold |
| Nov-05-21 | Upgrade | Barclays | Underweight → Equal Weight |
| Jun-24-21 | Upgrade | Deutsche Bank | Sell → Hold |
| Mar-23-21 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Feb-04-21 | Downgrade | Deutsche Bank | Hold → Sell |
| Jan-20-21 | Downgrade | Credit Suisse | Neutral → Underperform |
| Jan-15-21 | Initiated | Deutsche Bank | Hold |
| Nov-02-20 | Upgrade | Liberum | Hold → Buy |
| Sep-29-20 | Initiated | Berenberg | Buy |
| Feb-12-20 | Downgrade | Shore Capital | Hold → Sell |
| Jan-16-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Dec-02-19 | Initiated | SVB Leerink | Outperform |
| Nov-21-19 | Upgrade | UBS | Neutral → Buy |
| Oct-11-19 | Upgrade | Cantor Fitzgerald | Hold → Buy |
| Sep-03-19 | Resumed | Citigroup | Neutral |
| Sep-03-19 | Upgrade | Societe Generale | Sell → Buy |
| Aug-13-19 | Resumed | JP Morgan | Neutral |
| Jun-17-19 | Resumed | Morgan Stanley | Underweight |
| Mar-08-19 | Downgrade | Shore Capital | Buy → Hold |
| Feb-22-19 | Downgrade | UBS | Buy → Neutral |
| Jan-14-19 | Downgrade | Exane BNP Paribas | Outperform → Neutral |
| Dec-11-18 | Resumed | Jefferies | Buy |
| Oct-09-18 | Initiated | Guggenheim | Neutral |
| Aug-30-18 | Downgrade | Liberum | Buy → Hold |
| Apr-04-18 | Upgrade | Exane BNP Paribas | Neutral → Outperform |
| Mar-22-18 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Feb-09-18 | Upgrade | Kepler | Reduce → Hold |
View All
Gsk Plc Adr Stock (GSK) Latest News
GSK Beats on Q2 Earnings & Sales, Stock Gains on '25 Outlook Raise - TradingView
Adrenocortical Carcinoma Market Forecast upto 2034—Insights into Emerging Therapies and Market Trends | DelveInsight - GlobeNewswire Inc.
Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace
GSK Plc ADR (GSK) Stock: A Year of Stock Market Dynamics - investchronicle.com
Fifth Third Bancorp Inc. (FITB) Price Performance Over the Years: A Comparative Study - investchronicle.com
Navigating YMM Stock: Full Truck Alliance Co Ltd ADR Journey - investchronicle.com
GDS Holdings Limited ADR (GDS) Stock: Navigating a Year of Volatility - investchronicle.com
The Future of Microvast Holdings Inc: Analyzing MVST - investchronicle.com
SES AI Corporation (SES) Stock: Exploring a Year of Highs, Lows, and Trading Volume - investchronicle.com
SKYQ’s Stock Woes: Down -53.24% in 6 Months, Down -53.24% in Just 5 Days - investchronicle.com
Antero Resources Corp (AR) Stock: A Year of Declines and Increases - investchronicle.com
The Psychology of HUYA Inc ADR Inc. (HUYA) Price Performance: Understanding Market Sentiment - investchronicle.com
American Resources Corporation: Analyzing AREC Stock Trends - investchronicle.com
MSP Recovery Inc (MSPR) Stock: Navigating a Year of Stock Volatility - investchronicle.com
Coty Inc (COTY) Stock: A Year of Highs and Lows in the Market - investchronicle.com
Behind Palladyne AI Corp’s 52-Week Range: Uncovering Opportunities for Investors - investchronicle.com
NVO’s 2025 Market Dance: Down -51.70% – Time to Invest? - investchronicle.com
Celularity Inc (CELU) Stock: A Year of Market Fluctuations - investchronicle.com
Bilibili Inc ADR (BILI) Stock: Uncovering 52-Week Market Trends - investchronicle.com
Captivision Inc Inc. (CAPT) Price Performance: The Role of Supply and Demand - investchronicle.com
Charting the Course: Castellum Inc’s CTM Stock Prospects - investchronicle.com
MBIO Stock: Exploring Mustang Bio Inc’s Growth - investchronicle.com
IBG’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - investchronicle.com
IBIO’s Market Whiplash: -61.36% YTD Decline, -20.36% Plunge in 30 Days - investchronicle.com
LQR House Inc (YHC) Stock: A Year of Stock Market Dynamics - investchronicle.com
INKT’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com
Crossmark Global Holdings Inc. Reduces Stock Holdings in ARM Holdings PLC Sponsored ADR (NASDAQ:ARM) - Defense World
FDA Accepts GSK Filing for Expanded Use of RSV Shot in Younger Adults - The Globe and Mail
FDA Accepts GSK Filing For Expanded Use Of RSV Shot In Younger Adults - Barchart.com
Argentina Lithium & Energy (CVE:LIT) Shares Down 12.5% – What’s Next? - Defense World
Brown Advisory Inc. Increases Holdings in Invesco BulletShares 2026 Corporate Bond ETF (NASDAQ:BSCQ) - Defense World
Callan Capital LLC Raises Stock Holdings in Alphabet Inc. (NASDAQ:GOOGL) - Defense World
Brown Advisory Inc. Boosts Position in Schwab US Large-Cap ETF (NYSEARCA:SCHX) - Defense World
KBR, Inc. (NYSE:KBR) Holdings Trimmed by M&T Bank Corp - Defense World
Invesco RAFI Developed Markets ex-U.S. ETF (NYSEARCA:PXF) Position Increased by Bank of New York Mellon Corp - Defense World
Verisk Analytics, Inc. (NASDAQ:VRSK) Shares Sold by Stratos Wealth Partners LTD. - Defense World
Post Resch Tallon Group Inc. Has $818,000 Stock Position in NVIDIA Corporation (NASDAQ:NVDA) - Defense World
Alphabet Inc. (NASDAQ:GOOGL) Shares Purchased by Interchange Capital Partners LLC - Defense World
Crossmark Global Holdings Inc. Purchases New Stake in Cushman & Wakefield PLC (NYSE:CWK) - Defense World
4,270 Shares in iShares California Muni Bond ETF (NYSEARCA:CMF) Bought by Crossmark Global Holdings Inc. - Defense World
Wall Street Zen Upgrades LCI Industries (NYSE:LCII) to Buy - Defense World
Citigroup Forecasts Strong Price Appreciation for Establishment Labs (NASDAQ:ESTA) Stock - Defense World
Is Your Investment Portfolio Ready for a US-EU Trade Deal? - Morningstar
Amalgamated Bank Sells 311 Shares of Benchmark Electronics, Inc. (NYSE:BHE) - Defense World
Amalgamated Bank Has $429,000 Stock Position in NetScout Systems, Inc. (NASDAQ:NTCT) - Defense World
Amalgamated Bank Trims Stock Position in National Bank Holdings Corporation (NYSE:NBHC) - Defense World
GENFIT (NASDAQ:GNFT) Shares Up 0.7% – Time to Buy? - Defense World
LyondellBasell Industries NV (LYB) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com
Carrier Global Corp (CARR) Stock: Navigating a Year of Volatility - investchronicle.com
GSK's Specialty Medicines Unit On A Strong Footing: Here's Why - Barchart.com
GSK's Specialty Medicines Unit on a Strong Footing: Here's Why - Yahoo Finance
Gsk Plc Adr Stock (GSK) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.20%
0.46%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):